Oldest pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #1 to #50.
- Muscle-invasive Bladder Cancer (2017) (08:31, 14 December 2021)
- Open Radical Prostatectomy (08:57, 17 December 2021)
- Urothelial Cancer of the Prostate (09:00, 17 December 2021)
- Unresectable Locally Advanced and Metastatic Bladder Cancer (09:55, 17 December 2021)
- Segemental ureterectomy (14:35, 17 December 2021)
- Non-Germ Cell Tumours & Tumours of the Testicular Adnexa (10:44, 19 December 2021)
- Urethral Tumours (10:58, 19 December 2021)
- Ureters (11:10, 19 December 2021)
- Female Pelvis (12:17, 19 December 2021)
- Epididymis and Vas Deferens (12:46, 19 December 2021)
- Seminal Vesicles and Ejaculatory Ducts (12:48, 19 December 2021)
- Candiduria (17:57, 21 December 2021)
- CUA: Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020) (10:21, 22 March 2022)
- CUA: Prostate Cancer Screening (2017) (06:48, 23 March 2022)
- AUA: Clinically Localized Prostate Cancer (2017) (07:29, 23 March 2022)
- CUA: RCC Genetic Screening (2013) (11:28, 5 April 2022)
- Prostate Cancer: Pathology and TNM Staging (15:17, 5 April 2022)
- Adrenal Insufficiency (11:58, 29 September 2022)
- Adrenal: Benign Tumours (12:23, 29 September 2022)
- Retroperitoneal Fibrosis (18:46, 30 October 2022)
- Genitourinary Complications of Metabolic Syndrome (18:50, 30 October 2022)
- Renal Hypertension (18:56, 30 October 2022)
- Renal Transplant (19:05, 30 October 2022)
- Bladder and Testis Oncology (19:16, 30 October 2022)
- Pediatrics: Neuromuscular Disorders of the Lower Urinary Tract (06:27, 31 October 2022)
- Functional: Aging and Geriatric Urology (12:10, 4 November 2022)
- Infections: Clostridium Difficile Infection (12:22, 4 November 2022)
- CUA/AUA: Non-muscle Invasive Bladder Cancer (2021 CUA/2016 AUA)) (05:39, 11 November 2022)
- AUA: Surgical Management of LUTS due to BPH (2018) (12:11, 11 November 2022)
- CUA: Castrate-resistant Prostate Cancer (2021) (12:37, 11 November 2022)
- CUA: Androgen Deprivation Therapy: Adverse Events & Management (2021) (12:38, 11 November 2022)
- CUA: Testosterone Suppression (2018) (12:39, 11 November 2022)
- Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017) (12:40, 11 November 2022)
- CUA: Advanced and Metastatic Urothelial Cancer (2019) (12:40, 11 November 2022)
- CUA: Prostate Cancer Active Surveillance (2015) (12:41, 11 November 2022)
- CUA: Asymptomatic Microscopic Hematuria (2008) (12:44, 11 November 2022)
- CUA: Small Renal Masses (2015) (12:46, 11 November 2022)
- CUA: Surgical Management of RCC (2014) (12:46, 11 November 2022)
- CUA: Peyronie's Disease (2018) (12:47, 11 November 2022)
- CUA: Male LUTS & BPH (2018) (12:56, 11 November 2022)
- AUA: Prostate Cancer Screening (2018) (09:38, 4 January 2023)
- Scrotum & Spermatic Cord (17:30, 6 January 2023)
- Kidneys (20:32, 13 January 2023)
- Bladder (15:57, 19 January 2023)
- Orthotopic Urinary Diversion (17:35, 24 January 2023)
- CUA: Antibiotic Prophylaxis (2015) (12:48, 9 February 2023)
- CUA: Azoospermia (2015) (13:07, 9 February 2023)
- CUA: Circumcision (2018) (13:11, 9 February 2023)
- CUA: Cryptorchidism (2017) (13:23, 9 February 2023)
- CUA: Multicystic Dysplastic Kidney in the Neonate (2015) (13:25, 9 February 2023)